{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T02:52:20Z","timestamp":1793242340118,"version":"4.5.0"},"reference-count":25,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2010,3]]},"DOI":"10.1097\/md.0b013e3181d50928","type":"journal-article","created":{"date-parts":[[2010,3,4]],"date-time":"2010-03-04T01:36:00Z","timestamp":1267666560000},"page":"69-74","source":"Crossref","is-referenced-by-count":41,"title":["Familial and Sporadic Porphyria Cutanea Tarda"],"prefix":"10.1097","volume":"89","author":[{"given":"Carlos","family":"Mu\u00f1oz-Santos","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Guilabert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nemesio","family":"Moreno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jordi","family":"To-Figueras","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Celia","family":"Badenas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esteve","family":"Darwich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmen","family":"Herrero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-1-20210309","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1373\/clinchem.2008.117432","article-title":"Familial and sporadic porphyria cutanea tarda: characterization and diagnostic strategies.","volume":"55","author":"Aarsand","year":"2009","journal-title":"Clin Chem"},{"key":"R2-1-20210309","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1111\/j.1399-0004.2009.01153.x","article-title":"Identification and characterization of novel uroporphyrinogen decarboxylase gene mutations in a large series of porphyria cutanea tarda patients and relatives.","volume":"75","author":"Badenas","year":"2009","journal-title":"Clin Genet"},{"key":"R3-1-20210309","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1046\/j.1440-0960.2000.00437.x","article-title":"Porphyria cutanea tarda.","volume":"41","author":"Bleasel","year":"2000","journal-title":"Australas J Dermatol"},{"key":"R4-1-20210309","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1111\/j.1365-2230.1995.tb01288.x","article-title":"Hypertrichosis as the presenting feature of porphyria cutanea tarda.","volume":"20","author":"Boffa","year":"1995","journal-title":"Clin Exp Dermatol"},{"key":"R5-1-20210309","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1002\/hep.510270627","article-title":"Porphyria cutanea tarda, hepatitis C, and HFE gene mutations in North America.","volume":"27","author":"Bonkovsky","year":"1998","journal-title":"Hepatology"},{"key":"R6-1-20210309","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1046\/j.1523-1747.2000.00148.x","article-title":"Co-inheritance of mutations in the uroporphyrinogen decarboxylase and hemochromatosis genes accelerates the onset of porphyria cutanea tarda.","volume":"115","author":"Brady","year":"2000","journal-title":"J Invest Dermatol"},{"key":"R7-1-20210309","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1157\/13090276","article-title":"Hepatitis C in Spain.","volume":"127","author":"Bruguera","year":"2006","journal-title":"Med Clin (Barc)"},{"key":"R8-1-20210309","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1080\/00015550310007454","article-title":"Familial and sporadic porphyria cutanea tarda: clinical, biochemical and genetic features with emphasis on iron status.","volume":"83","author":"Bygum","year":"2003","journal-title":"Acta Derm Venereol"},{"key":"R9-1-20210309","first-page":"845","article-title":"Precipitating\/aggravating factors of porphyria cutanea tarda in Spanish patients.","volume":"48","author":"Cruz-Rojo","year":"2002","journal-title":"Cell Mol Biol (Noisy-le-grand)"},{"key":"R10-1-20210309","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1055\/s-2007-1007142","article-title":"Porphyria cutanea tarda.","volume":"18","author":"Elder","year":"1998","journal-title":"Semin Liver Dis"},{"key":"R12-1-20210309","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/0002-9343(79)90403-0","article-title":"Porphyria cutanea tarda. Clinical features and laboratory findings in 40 patients.","volume":"67","author":"Grossman","year":"1979","journal-title":"Am J Med"},{"key":"R13-1-20210309","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1016\/0140-6736(93)90562-U","article-title":"Is hepatitis C virus infection a trigger of porphyria cutanea tarda?","volume":"341","author":"Herrero","year":"1993","journal-title":"Lancet"},{"key":"R14-1-20210309","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1111\/j.1365-2133.1992.tb11816.x","article-title":"Erythrocyte uroporphyrinogen decarboxylase activity in 80 unrelated patients with porphyria cutanea tarda.","volume":"126","author":"Koszo","year":"1992","journal-title":"Br J Dermatol"},{"key":"R15-1-20210309","first-page":"235","article-title":"Pregnancy and porphyria cutanea tarda.","volume":"145","author":"Lamon","year":"1979","journal-title":"Johns Hopkins Med J"},{"key":"R16-1-20210309","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0009-8981(84)90192-X","article-title":"Urine and faecal porphyrin profiles by reversed-phase high-performance liquid chromatography in the porphyrias.","volume":"139","author":"Lim","year":"1984","journal-title":"Clin Chim Acta"},{"key":"R17-1-20210309","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1111\/j.0954-6820.1970.tb08003.x","article-title":"Iron storage in porphyria cutanea tarda.","volume":"1-","author":"Lundvall","year":"1970","journal-title":"Acta Med Scand"},{"key":"R18-1-20210309","doi-asserted-by":"crossref","first-page":"2355","DOI":"10.1093\/clinchem\/34.11.2355","article-title":"An assay of uroporphyrinogen decarboxylase in erythrocytes.","volume":"34","author":"McManus","year":"1988","journal-title":"Clin Chem"},{"key":"R19-1-20210309","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.jaad.2004.09.014","article-title":"The role of inherited and acquired factors in the development of porphyria cutanea tarda in the Argentinean population.","volume":"52","author":"Mendez","year":"2005","journal-title":"J Am Acad Dermatol"},{"key":"R20-1-20210309","first-page":"262","article-title":"Cutaneous pigmentation, only manifestation of porphyria cutanea tarda in a HIV-1 positive patient.","volume":"123","author":"Pascual","year":"1996","journal-title":"Ann Dermatol Venereol"},{"key":"R21-1-20210309","first-page":"1","article-title":"The treatment of porphyria cutanea tarda by venesection.","volume":"43","author":"Ramsay","year":"1974","journal-title":"Q J Med"},{"key":"R22-1-20210309","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1080\/00015550510033688","article-title":"Porphyria cutanea tarda in a Swedish population: risk factors and complications.","volume":"85","author":"Rossmann-Ringdahl","year":"2005","journal-title":"Acta Derm Venereol"},{"key":"R23-1-20210309","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1046\/j.1365-2230.2001.00825.x","article-title":"The management of porphyria cutanea tarda.","volume":"26","author":"Sarkany","year":"2001","journal-title":"Clin Exp Dermatol"},{"key":"R24-1-20210309","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/S0168-8278(95)80004-2","article-title":"The difference in liver pathology between sporadic and familial forms of porphyria cutanea tarda: the role of iron.","volume":"23","author":"Siersema","year":"1995","journal-title":"J Hepatol"},{"key":"R25-1-20210309","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1080\/003655100448338","article-title":"Porphyrins, porphyrin metabolism, porphyrias. III. Diagnosis, care and monitoring in porphyria cutanea tarda-suggestions for a handling programme.","volume":"60","author":"Thunell","year":"2000","journal-title":"Scand J Clin Lab Invest"},{"key":"R26-1-20210309","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1111\/j.1468-3083.2006.01746.x","article-title":"The prevalence of HFE C282Y gene mutation is increased in Spanish patients with porphyria cutanea tarda without hepatitis C virus infection.","volume":"20","author":"Toll","year":"2006","journal-title":"J Eur Acad Dermatol Venereol"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0b013e3181d50928","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T18:19:46Z","timestamp":1786040386000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00005792-201003000-00001"}},"subtitle":["Clinical and Biochemical Features and Risk Factors in 152 Patients"],"short-title":[],"issued":{"date-parts":[[2010,3]]},"references-count":25,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2010]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0b013e3181d50928","relation":{},"ISSN":["0025-7974"],"issn-type":[{"value":"0025-7974","type":"print"}],"subject":[],"published":{"date-parts":[[2010,3]]}}}